Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 2
1990 4
1991 4
1992 6
1993 8
1994 3
1995 4
1996 1
1997 5
1998 7
1999 7
2000 7
2001 4
2002 13
2003 8
2004 3
2005 9
2006 5
2007 1
2008 6
2009 6
2010 2
2011 5
2012 2
2013 2
2014 4
2015 2
2016 2
2017 1
2018 1
2020 1
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A. Tumeh PC, et al. Among authors: glaspy ja. Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954. Nature. 2014. PMID: 25428505 Free PMC article. Clinical Trial.
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Shi H, Hugo W, Kong X, Hong A, Koya RC, Moriceau G, Chodon T, Guo R, Johnson DB, Dahlman KB, Kelley MC, Kefford RF, Chmielowski B, Glaspy JA, Sosman JA, van Baren N, Long GV, Ribas A, Lo RS. Shi H, et al. Among authors: glaspy ja. Cancer Discov. 2014 Jan;4(1):80-93. doi: 10.1158/2159-8290.CD-13-0642. Epub 2013 Nov 21. Cancer Discov. 2014. PMID: 24265155 Free PMC article.
Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial.
Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK. Rugo HS, et al. Among authors: glaspy ja. Lancet Oncol. 2017 May;18(5):654-662. doi: 10.1016/S1470-2045(17)30109-2. Epub 2017 Mar 15. Lancet Oncol. 2017. PMID: 28314691 Clinical Trial.
Erythropoietin in cancer patients.
Glaspy JA. Glaspy JA. Annu Rev Med. 2009;60:181-92. doi: 10.1146/annurev.med.60.050307.110718. Annu Rev Med. 2009. PMID: 18980468 Review.
Financial Toxicity From Generic Specialty Drug Use.
Fischer KA, Miller RE, Glaspy JA. Fischer KA, et al. Among authors: glaspy ja. JAMA Oncol. 2021 Feb 1;7(2):175-176. doi: 10.1001/jamaoncol.2020.5181. JAMA Oncol. 2021. PMID: 33211083 No abstract available.
Cancer patient survival and erythropoietin.
Glaspy JA. Glaspy JA. J Natl Compr Canc Netw. 2005 Nov;3(6):796-804. doi: 10.6004/jnccn.2005.0048. J Natl Compr Canc Netw. 2005. PMID: 16316615 Review.
Cancer immunotherapy using gene-modified dendritic cells.
Ribas A, Butterfield LH, Glaspy JA, Economou JS. Ribas A, et al. Among authors: glaspy ja. Curr Gene Ther. 2002 Feb;2(1):57-78. doi: 10.2174/1566523023348129. Curr Gene Ther. 2002. PMID: 12108974 Review.
139 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page